Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

3 No-Brainer Dividend Stocks to Buy in April


Three Motley Fool contributors have dividends on their minds as the second quarter of 2024 begins. And they think they've found some no-brainer dividend stocks to buy in April. Here's why they like (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).

Keith Speights (AbbVie): What's better than a high-dividend yield? I'd say a high-dividend yield combined with a growing dividend. That's exactly what you'll get with AbbVie.

Let's start with the biopharmaceutical company's dividend yield of nearly 3.6%. High yields aren't unusual for AbbVie. The yield has topped 3% throughout most of its history.

Continue reading


Source Fool.com

AbbVie Inc. Stock

€152.18
1.590%
AbbVie Inc. gained 1.590% today.
The stock is an absolute favorite of our community with 21 Buy predictions and no Sell predictions.
As a result the target price of 174 € shows a slightly positive potential of 14.34% compared to the current price of 152.18 € for AbbVie Inc..
Like: 0
Share

Comments